| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/09/2005 | EP1453816A4 Phenoxy amine compounds and compositions for delivering active agents |
| 02/09/2005 | EP1436252A4 Hydroxyfattysulfonic acid analogs |
| 02/09/2005 | EP1432436A4 Nutrient therapy for immuno-compromised patients |
| 02/09/2005 | EP1430047B1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/09/2005 | EP1430034B1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/09/2005 | EP1423132A4 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 02/09/2005 | EP1420802A4 Increased solubility flavanolignan preparations |
| 02/09/2005 | EP1414816B1 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments |
| 02/09/2005 | EP1401446B1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen |
| 02/09/2005 | EP1392285B1 Medicament containing an effector of the glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy |
| 02/09/2005 | EP1390031B1 Topical composition containing a fungicide |
| 02/09/2005 | EP1387683B1 Novel salt and crystalline forms of (2r)-anti-5-3-(4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl)-2-hydroxypropoxy quinoline |
| 02/09/2005 | EP1385854B1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 02/09/2005 | EP1370268A4 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 02/09/2005 | EP1349846B1 Arylated furane and thiophene carboxylic acid amides with potassium channel blocking effect |
| 02/09/2005 | EP1349839B1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/09/2005 | EP1339717B1 Novel carbamate-substituted pyrazolopyridine derivatives |
| 02/09/2005 | EP1313885A4 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 02/09/2005 | EP1307209B1 Cardioplegic solution |
| 02/09/2005 | EP1299059A4 Method and manufacture of a wound dressing for covering an open wound |
| 02/09/2005 | EP1296703B1 Non-antibacterial tetracycline as anti-fungal agents |
| 02/09/2005 | EP1294705A4 Synthesis of cyclic compounds |
| 02/09/2005 | EP1284601A4 Allantoin-containing skin cream |
| 02/09/2005 | EP1280805B1 Novel imidazotriazinones and the use thereof |
| 02/09/2005 | EP1280535B1 Processes for preparing clarithromycin polymorphs |
| 02/09/2005 | EP1280525B1 Methods and compositions for modulating alpha adrenergic receptor activity |
| 02/09/2005 | EP1274980A4 Solution and crystal structures of mmp-13 active site and uses thereof |
| 02/09/2005 | EP1255850A4 AMPLIFICATION OF $i(CYP24) AND USES THEREOF |
| 02/09/2005 | EP1244640B1 Oxazolidinone derivatives |
| 02/09/2005 | EP1235799B1 Polymorphic form of atorvastatin calcium |
| 02/09/2005 | EP1223927B1 Use of retigabin for treating neuropathic pain |
| 02/09/2005 | EP1214939B1 Ppar alpha and ppar gamma inhibitors |
| 02/09/2005 | EP1210119B1 Pharmaceutical compositions for oral and topical administration |
| 02/09/2005 | EP1200076A4 Calcilytic compounds |
| 02/09/2005 | EP1191924A4 Pharmaceutical dosage form for pulsatile delivery of (d-threo)-methylphenidate and a second cns stimulant |
| 02/09/2005 | EP1184366B1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha(ppar) |
| 02/09/2005 | EP1181024B1 Use of glycosaminoglycans for the treatment of senile dementia |
| 02/09/2005 | EP1175154B1 Method for manufacturing rumen bypass feed supplement |
| 02/09/2005 | EP1165054A4 Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
| 02/09/2005 | EP1162982B1 USE OF STABILISED OLIGONUCLEOTIDES FOR PREPARING A MEDICament WITH ANTITUMOUR ACTIVITY |
| 02/09/2005 | EP1150960B1 Polymorphic crystalline forms of celecoxib |
| 02/09/2005 | EP1140939B1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidines, and related pharmaceutical compositions and methods |
| 02/09/2005 | EP1117399B1 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
| 02/09/2005 | EP1111995B1 Topical dermal antimicrobial compositions |
| 02/09/2005 | EP1105376B1 Oxindole derivatives as growth hormone releasers |
| 02/09/2005 | EP1098639B1 Use of the glucose uptake enhancer rosiglitazone for reducing ischaemia-induced apoptosis of pancreatic beta cells, endothelial cells and neuronal cells |
| 02/09/2005 | EP1096919B1 Endoscopic transluminal delivery device comprising a pellet containing a local anesthetic agent |
| 02/09/2005 | EP1087951B1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 02/09/2005 | EP1079813B1 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 02/09/2005 | EP1071417B1 Use of cannabidiol as anti-inflammatory agent |
| 02/09/2005 | EP1044202B1 1'- 4- 1- (4-fluorophenyl)- 1h-indole-3-yl] -1-butyl]-spiro isobenzofuran- 1(3h),4'- piperidine] hydrohalogenides |
| 02/09/2005 | EP1042316B1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 02/09/2005 | EP1027015B1 Controlled release of pharmaceuticals in the anterior chamber of the eye |
| 02/09/2005 | EP0971705B1 Hormone replacement therapy drug formulations for topical application to the skin |
| 02/09/2005 | EP0957927B1 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation |
| 02/09/2005 | EP0941093B1 Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety |
| 02/09/2005 | EP0934310B1 Thio acid derived monocyclic n-heterocyclics as anticoagulants |
| 02/09/2005 | EP0900210B1 Antivirally active heterocyclic azahexane derivatives |
| 02/09/2005 | EP0863896B1 Novel imidazole derivatives, method for preparing same, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 02/09/2005 | CN1578840A Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
| 02/09/2005 | CN1578786A Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/09/2005 | CN1578782A Silicon compounds |
| 02/09/2005 | CN1578781A 1, 8 naphthyridine derivatives and their use to treat diabetes and related disorders |
| 02/09/2005 | CN1578780A 1, 6-naphthyridine derivatives as antidiabetics and pharmaceutical compositions containing them |
| 02/09/2005 | CN1578779A Small organic molecule regulators of cell proliferation |
| 02/09/2005 | CN1578778A Tetrahydropyran derivatives and their use as therapeutic agents |
| 02/09/2005 | CN1578776A Heterocyclic retinoid compounds |
| 02/09/2005 | CN1578775A 3-amido-1, 2-benzoisoxazole derivatives, process for preparation, and use thereof |
| 02/09/2005 | CN1578773A Methods and compositions of novel triazine compounds |
| 02/09/2005 | CN1578772A Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 02/09/2005 | CN1578768A Anthranilic acid amides and pharmaceutical use thereof |
| 02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2005 | CN1578724A System, method and apparatus for producing dosage forms |
| 02/09/2005 | CN1578677A Improved therapeutic protocols |
| 02/09/2005 | CN1578676A Lox concentration of peroxide for treating or preventing vaginal infections |
| 02/09/2005 | CN1578675A Extended, controlled-release pharmaceutical compositions using charged polymers |
| 02/09/2005 | CN1578674A Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 02/09/2005 | CN1578672A Rsv基因表达疫苗 Rsv gene expression vaccine |
| 02/09/2005 | CN1578669A Compositions and methods for treating subjects with hyperglycemia |
| 02/09/2005 | CN1578668A Salvianolic acid b |
| 02/09/2005 | CN1578667A Anticancer compositions |
| 02/09/2005 | CN1578666A D-mannose contraceptives |
| 02/09/2005 | CN1578665A Type 4 phosphodiesterase inhibitors and uses thereof |
| 02/09/2005 | CN1578664A Depot formulations of iloperidone and a star polymer |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578662A Pyridine derivatives as nmda-receptor subtype blockers |
| 02/09/2005 | CN1578661A Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 02/09/2005 | CN1578660A Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
| 02/09/2005 | CN1578658A Metal organic antitumour agent |
| 02/09/2005 | CN1578657A Process for the preparation of fast dissolving dosage form |
| 02/09/2005 | CN1578653A Cosmetics and treatment method for promoting maturation of cornified envelopes |
| 02/09/2005 | CN1578650A Compositions for the treatment of infectious diseases |
| 02/09/2005 | CN1578647A Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 02/09/2005 | CN1578626A Multivesicular emulsion topical delivery systems |
| 02/09/2005 | CN1578624A Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability |
| 02/09/2005 | CN1578497A Radio base station, radio communication system, communication control method of cell station |
| 02/09/2005 | CN1576277A New derivatives of benzo[a]pyrano[3, 2-h]acridin-7-one, a process for their preparation and pharmaceutical compounds containing them |
| 02/09/2005 | CN1576275A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 02/09/2005 | CN1576269A N-<l- deoxyglucose alcoho1-1-radical> amino acid and producing process and use thereof |